References
Allen, T.: A study of phospholipid interactions between high density lipoprotein and small unilamellar vesicles. Biochimica Biophysica Acta 640: 385–397 (1981).
Barbet, J.; Machy, P. and Leserman, L.D.: Monoclonal antibody covalently coupled to liposomes: specific targeting to cells. Journal of Supramolecular Structure 16: 243–258 (1981).
Bartal, A.H.; Feit, C.; Erlandson, R. and Hirshaut, V.: The presence of viral particles in hybridoma clones secreting monoclonal antibodies. New England Journal of Medicine 306: 1423 (1982).
Blytham, H.E.; Casellas, P.; Gross, O.; Gross, P.; Jansen, F.K.; Paolucci, F.; Pan, B. and Vidal, H.: Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells. Nature 290: 145–146 (1981).
Damen, J.; Regts, J. and Scherphof, G.: Transfer and exchange of phospholipid between small unilamellar liposomes and rat plasma high density lipoproteins. Biochimica et Biophysica Acta 665: 538–545 (1981).
Edwards, P.A.W.: Some properties and applications of monoclonal antibodies. Biochemical Journal 200: 1–10 (1981).
Ellens, H.; Morselt, H. and Scherphof, G.: In vivo fate of large unilamellar sphingomyelin-cholesterol liposomes after intraperitoneal and intravenous injection into rats. Biochimica Biophysica Acta 674: 10–18 (1981).
Froese, G.; Berczi, I. and Israels, L.G.: Tumour-cell antibody interactions. Immunology 45: 313–323 (1982).
Ghosh, P.; Das, P.K. and Bachhawat, B.K.: Targeting of liposomes towards different cell types of rat liver through the involvement of liposomal surface glycosides. Archives of Biochemistry and Biophysics 213: 266–270 (1982).
Gilliland, D.G.; Stephlewski, Z.; Collier, R.J.; Mitchell, K.F.; Chang, T.H. and Koprowski, H.: Antibody-directed cytotoxic agents. Use of monoclonal antibody to direct action of toxin A chains; to colerectal carcinoma cells. Proceedings of the National Academy of Sciences, USA 77: 4539–4543 (1980).
Gregoriadis, G.: Catabolism of glycoproteins; in Dingle and Dean (Eds) Lysosomes in Biology and Pathology, pp.265–294 (North Holland, Amsterdam, Oxford 1975).
Gregoriadis, G.: The carrier potential of liposomes in biology and medicine. New England Journal of Medicine 295: 704–710; 765-770 (1976).
Gregoriadis, G.: Tailoring liposome structure. Nature 283: 814–815 (1980).
Gregoriadis, G.: Targeting of drugs: Implications in medicine. Lancet 2: 241–247 (1981a).
Gregoriadis, G.: Liposomes: a role in vaccines? Clinical Immunology Newsletter 2: 33–36 (1981b).
Gregoriadis, G. and Meehan, A.: Interaction of antibody-bearing small unilamellar liposomes with antigen coated cells: the effect of antibody and antigen concentration on the liposomal and cell surface respectively. Biochemical Journal 200: 211–216 (1981).
Gregoriadis, G. and Senior, J.: The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the circulation. FEBS Letters 119: 43–46 (1980).
Gregoriadis, G.; Senior, J. and Trouet, A. (Eds): Targeting of Drugs (Plenum Press, London, New York 1982).
Hart, I.R.; Fogler, W.E.; Poste, G. and Fidler, I.: Toxicity studies of liposome-encapsulated immunomodulators administered intravenously to dogs and mice. Cancer Immunology and Immunotherapy 10: 157–166 (1981).
Huang, A.; Huang, L. and Kennel, S.J.: Monoclonal antibody covalently coupled with fatty acid. Journal of Biological Chemistry 255: 8015–8018 (1980).
Kaye, S.B.: Liposomes — problems and promise as selective drug carriers. Cancer Treatment Reviews 8: 27–50 (1981).
Khato, J.; Priester, E.R. and Sieber, S.M.: Enhanced lymph node uptake of melphalan following liposomal entrapment and effects on lymph node metastasis in rats. Cancer Treatment Reports 66: 517–527 (1982).
Kirby, C. and Gregoriadis, G.: Plasma-induced release of solutes from small unilamellar liposomes is associated with pore formation in the bilayers. Biochemical Journal 199: 251–254 (1981).
Kirby, C.; Clarke, J. and Gregoriadis, G.: Cholesterol content of small unilamellar liposomes controls phospholipid loss to high density lipoproteins in the presence of serum. FEBS Letters III: 324–328 (1980a).
Kirby, C.; Clarke, J. and Gregoriadis, G.: Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochemical Journal 186: 591–598 (1980b).
Krolick, K.A.; Uhr, J.W. and Vitetta, E.S.: Selective killing of leukaemia cells by antibody-toxin conjugates: implications for autologous bone marrow transplantation. Nature 295: 604–605 (1982).
Levine, G.; Ballou, B.; Reiland, J.; Solter, D.; Gumerman, L. and Hakala, T.: Localization of 131I-labelled tumour-specific monoclonal antibody in the tumour-bearing BALB/c mouse. Journal of Nuclear Medicine 21: 570–573 (1980).
Mach, J-P.; Buchegger, F.; Forni, M.; Ritzchard, J.; Berche, C.; Lumboso, J-D; Schreyer, M.; Giradet, C.; Accolla, R.S. and Carrel, S.: Use of radiolabelled monoclonal anti-CES antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. Immunology Today 2: 239–249 (1981).
Martin, F.J.; Hubbell, W.L. and Papahadjopoulos, D.: Immunospecific targeting of liposomes to cells: A novel and efficient method for covalent attachment of Fab’ fragments via disulfide bonds. Biochemistry 20: 4229–4238 (1981).
Marx, J.L.: Monoclonal antibodies in cancer. Science 216: 283–285 (1982).
Mauk, M.R.; Gamble, R.C. and Baldeschwieler, J.D.: Targeting of lipid vesicles: specificity of carbohydrate receptor analogues for leucocytes in mice. Proceedings of the National Academy of Science, USA 77: 4430–4434 (1980).
McCullough, H.N. and Juliano, R.L.: Organ-selective action of an antitumour drug: Pharmacologic studies of liposome-encapsulated cytosine arabinoside administered via the respiratory system of the rat. Journal of National Cancer Institute 63: 727–731 (1979).
Milstein, G: Monoclonal antibodies. Scientific American 243(4): 56–64 (1980).
Moshakis, V.; McIlhinney, R.A.J. and Neville, A.M.: Cellular distribution of monoclonal antibody in human tumours after i.v. administration. British Journal of Cancer 44: 663–669 (1981).
Olsnes, S.: Directing toxins to cancer cells. Nature 190: 84 (1981).
O’Neill, G.J.: The use of antibodies as drug carriers; in Gregoriadis (Ed.) Drug Carriers in Biology and Medicine pp.23–41 (Academic Press, London, New York 1979).
Rahman, Y-E.: Liposomes and chelating agents; in Gregoriadis and Allison (Eds) Liposomes in Biological Systems pp.265–298 (John Wiley and Sons, Chichester, New York 1980).
Ryman, B.E. and Tyrrell, D.A.: Liposomes — bags of potential. Essays in Biochemistry 16: 49–98 (1980).
Scheinberg, D.A. and Strand, M.: Tumour imaging with radioactive metal chelates conjugated to monoclonal antibodies. Science 215: 1511–1513 (1982).
Sikora, K.; Alderson, T.; Phillips, J. and Watson, J.V.: Human hybridomas from malignant gliomas. Lancet 1: 11–14 (1982).
Tom, B.H. and Six, H.R. (Eds): Liposomes and Immunobiology (Elsevier/North Holland, New York, Amsterdam 1980).
Yatvin, M.B.; Mühlensiepen, H.; Proschen, W.; Weinstein, J.N. and Feinendegen, L.E.: Selective delivery of liposome-associated cisdichlorodiammineplatinum (II) by heat and its influence on tumour drug uptake and growth. Cancer Research 41: 1602–1607 (1981).
Youle, R.J. and Neville, D.M. Jr: Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell type specific toxin. Proceedings of the National Academy of Sciences, USA 77: 5483–5486 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gregoriadis, G. Use of Monoclonal Antibodies and Liposomes to Improve Drug Delivery. Drugs 24, 261–266 (1982). https://doi.org/10.2165/00003495-198224040-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198224040-00001